VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,091,305 | -50.8% | 116,468 | +28.8% | 0.00% | -100.0% |
Q2 2023 | $2,218,493 | +35.9% | 90,440 | +29.0% | 0.00% | – |
Q1 2023 | $1,631,855 | +922.9% | 70,127 | +1012.6% | 0.00% | – |
Q4 2022 | $159,530 | -27.2% | 6,303 | -44.5% | 0.00% | – |
Q3 2022 | $219,000 | -32.6% | 11,363 | -10.9% | 0.00% | – |
Q2 2022 | $325,000 | -70.1% | 12,748 | -69.8% | 0.00% | – |
Q1 2022 | $1,086,000 | -56.9% | 42,219 | -29.8% | 0.00% | -100.0% |
Q4 2021 | $2,519,000 | -4.4% | 60,182 | -0.6% | 0.00% | 0.0% |
Q3 2021 | $2,635,000 | +212.9% | 60,559 | +240.3% | 0.00% | – |
Q2 2021 | $842,000 | -27.0% | 17,798 | -20.9% | 0.00% | – |
Q1 2021 | $1,154,000 | -57.0% | 22,509 | -77.5% | 0.00% | -100.0% |
Q4 2020 | $2,681,000 | +89.1% | 100,111 | +142.2% | 0.00% | – |
Q3 2020 | $1,418,000 | -48.8% | 41,340 | -38.9% | 0.00% | -100.0% |
Q2 2020 | $2,771,000 | +575.9% | 67,634 | +465.5% | 0.00% | – |
Q1 2020 | $410,000 | +5757.1% | 11,960 | +1937.5% | 0.00% | – |
Q4 2019 | $7,000 | – | 587 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
Capital International Investors | 983,300 | $12,365,000 | 0.00% |
Blackstone Inc. | 35,000 | $440,000 | 0.00% |
Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |